Optimization of alkylidene hydrazide based human glucagon receptor antagonists. Discovery of the highly potent and orally available 3-cyano-4-hydroxybenzoic acid [1-(2,3,5,6-tetramethylbenzyl)-1H-indol-4-ylmethylene]hydrazide. (Q30873914)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Optimization of alkylidene hydrazide based human glucagon receptor antagonists. Discovery of the highly potent and orally available 3-cyano-4-hydroxybenzoic acid [1-(2,3,5,6-tetramethylbenzyl)-1H-indol-4-ylmethylene]hydrazide. |
scientific article |
Statements
Optimization of alkylidene hydrazide based human glucagon receptor antagonists. Discovery of the highly potent and orally available 3-cyano-4-hydroxybenzoic acid [1-(2,3,5,6-tetramethylbenzyl)-1H-indol-4-ylmethylene]hydrazide (English)
Peter Madsen
Anthony Ling
Michael Plewe
Christian K Sams
Ulla G Sidelmann
Lars Ynddal
Christian L Brand
Birgitte Andersen
Douglas Murphy
Min Teng
Larry Truesdale
Dan Kiel
John May
Atsuo Kuki
Shenghua Shi
Michael D Johnson
Kimberly Ann Teston
Jun Feng
James Lakis
Kenna Anderes
Vlad Gregor
1 December 2002